297 related articles for article (PubMed ID: 32503272)
1. Bisphosphonate-Based Molecules as Potential New Antiparasitic Drugs.
Branco Santos JC; de Melo JA; Maheshwari S; de Medeiros WMTQ; de Freitas Oliveira JW; Moreno CJ; Mario Amzel L; Gabelli SB; Sousa Silva M
Molecules; 2020 Jun; 25(11):. PubMed ID: 32503272
[TBL] [Abstract][Full Text] [Related]
2. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis.
Lepesheva GI; Waterman MR
Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513
[TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
4. Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis.
Caballero AB; Rodríguez-Diéguez A; Quirós M; Salas JM; Huertas Ó; Ramírez-Macías I; Olmo F; Marín C; Chaves-Lemaur G; Gutierrez-Sánchez R; Sánchez-Moreno M
Eur J Med Chem; 2014 Oct; 85():526-34. PubMed ID: 25127147
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids.
Magoulas GE; Afroudakis P; Georgikopoulou K; Roussaki M; Borsari C; Fotopoulou T; Santarem N; Barrias E; Tejera Nevado P; Hachenberg J; Bifeld E; Ellinger B; Kuzikov M; Fragiadaki I; Scoulica E; Clos J; Gul S; Costi MP; de Souza W; Prousis KC; Cordeiro da Silva A; Calogeropoulou T
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299479
[TBL] [Abstract][Full Text] [Related]
6. A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids.
Aguilera E; Perdomo C; Espindola A; Corvo I; Faral-Tello P; Robello C; Serna E; Benítez F; Riveros R; Torres S; Vera de Bilbao NI; Yaluff G; Alvarez G
Molecules; 2019 Oct; 24(20):. PubMed ID: 31652542
[TBL] [Abstract][Full Text] [Related]
7. Lanthanide complexes containing 5-methyl-1,2,4-triazolo[1,5-a] pyrimidin-7(4H)-one and their therapeutic potential to fight leishmaniasis and Chagas disease.
Caballero AB; Rodríguez-Diéguez A; Salas JM; Sánchez-Moreno M; Marín C; Ramírez-Macías I; Santamaría-Díaz N; Gutiérrez-Sánchez R
J Inorg Biochem; 2014 Sep; 138():39-46. PubMed ID: 24861807
[TBL] [Abstract][Full Text] [Related]
8. New alkenyl derivative from Piper malacophyllum and analogues: Antiparasitic activity against Trypanosoma cruzi and Leishmania infantum.
Varela MT; Lima ML; Galuppo MK; Tempone AG; de Oliveira A; Lago JHG; Fernandes JPS
Chem Biol Drug Des; 2017 Nov; 90(5):1007-1011. PubMed ID: 28371557
[TBL] [Abstract][Full Text] [Related]
9. Targeting calcium homeostasis as the therapy of Chagas' disease and leishmaniasis - a review.
Benaim B; Garcia CR
Trop Biomed; 2011 Dec; 28(3):471-81. PubMed ID: 22433874
[TBL] [Abstract][Full Text] [Related]
10. Isolation, Derivative Synthesis, and Structure-Activity Relationships of Antiparasitic Bromopyrrole Alkaloids from the Marine Sponge Tedania brasiliensis.
Parra LLL; Bertonha AF; Severo IRM; Aguiar ACC; de Souza GE; Oliva G; Guido RVC; Grazzia N; Costa TR; Miguel DC; Gadelha FR; Ferreira AG; Hajdu E; Romo D; Berlinck RGS
J Nat Prod; 2018 Jan; 81(1):188-202. PubMed ID: 29297684
[TBL] [Abstract][Full Text] [Related]
11. Application of Dithiocarbamates as Potential New Antitrypanosomatids-Drugs: Approach Chemistry, Functional and Biological.
Oliveira JWF; Rocha HAO; de Medeiros WMTQ; Silva MS
Molecules; 2019 Aug; 24(15):. PubMed ID: 31374887
[TBL] [Abstract][Full Text] [Related]
12. Novel chemical starting points for drug discovery in leishmaniasis and Chagas disease.
Roquero I; Cantizani J; Cotillo I; Manzano MP; Kessler A; Martín JJ; McNamara CW
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():58-68. PubMed ID: 31158574
[TBL] [Abstract][Full Text] [Related]
13. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy.
Santi AMM; Murta SMF
Mem Inst Oswaldo Cruz; 2022; 117():e210401. PubMed ID: 35239945
[TBL] [Abstract][Full Text] [Related]
15. Antiparasitic activity and effect of casearins isolated from Casearia sylvestris on Leishmania and Trypanosoma cruzi plasma membrane.
Bou DD; Tempone AG; Pinto ÉG; Lago JH; Sartorelli P
Phytomedicine; 2014 Apr; 21(5):676-81. PubMed ID: 24560122
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
[TBL] [Abstract][Full Text] [Related]
17. The kinetoplastid chemotherapy revisited: current drugs, recent advances and future perspectives.
Castillo E; Dea-Ayuela MA; Bolás-Fernández F; Rangel M; González-Rosende ME
Curr Med Chem; 2010; 17(33):4027-51. PubMed ID: 20939823
[TBL] [Abstract][Full Text] [Related]
18. Germacranolide-type sesquiterpene lactones from Smallanthus sonchifolius with promising activity against Leishmania mexicana and Trypanosoma cruzi.
Ulloa JL; Spina R; Casasco A; Petray PB; Martino V; Sosa MA; Frank FM; Muschietti LV
Parasit Vectors; 2017 Nov; 10(1):567. PubMed ID: 29132413
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi.
Tempone AG; Ferreira DD; Lima ML; Costa Silva TA; Borborema SET; Reimão JQ; Galuppo MK; Guerra JM; Russell AJ; Wynne GM; Lai RYL; Cadelis MM; Copp BR
Eur J Med Chem; 2017 Oct; 139():947-960. PubMed ID: 28881289
[TBL] [Abstract][Full Text] [Related]
20. Cysteine synthase: multiple structures of a key enzyme in cysteine synthesis and a potential drug target for Chagas disease and leishmaniasis.
Sowerby K; Freitag-Pohl S; Murillo AM; Silber AM; Pohl E
Acta Crystallogr D Struct Biol; 2023 Jun; 79(Pt 6):518-530. PubMed ID: 37204818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
